Yahoo
NasdaqCM - Delayed Quote USD

Corcept Therapeutics Incorporated (CORT)

111.62 -1.18 (-1.05%)
At close: September 4 at 4:00:00 PM EDT
113.74 +2.12 (+1.90%)
After hours: September 4 at 7:55:18 PM EDT
Trade CORT on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
830,813
761,407
675,040
482,375
401,858
Cost of Revenue
14,085
12,977
10,882
6,481
5,385
Gross Profit
816,728
748,430
664,158
475,894
396,473
Operating Expense
810,323
703,633
527,207
368,612
283,839
Operating Income
6,405
44,797
136,951
107,282
112,634
Net Non Operating Interest Income Expense
19,964
21,666
24,542
17,275
3,557
Pretax Income
26,369
66,463
161,493
124,557
116,191
Tax Provision
-28,813
-33,189
20,284
18,417
14,773
Net Income Common Stockholders
54,270
98,171
139,733
105,496
101,288
Diluted NI Available to Com Stockholders
54,270
98,171
139,733
105,496
101,288
Basic EPS
0.53
0.95
1.35
1.02
0.95
Diluted EPS
0.45
0.82
1.23
0.94
0.87
Basic Average Shares
104,262.50
103,862
103,232
103,560
106,787
Diluted Average Shares
118,060
119,987
113,480
111,742
115,966
Total Operating Income as Reported
6,405
44,797
136,951
107,282
112,634
Total Expenses
824,408
716,610
538,089
375,093
289,224
Net Income from Continuing & Discontinued Operation
55,182
99,652
141,209
106,140
101,418
Normalized Income
55,182
99,652
141,209
106,140
101,418
Interest Income
19,964
21,666
24,542
17,275
3,557
Net Interest Income
19,964
21,666
24,542
17,275
3,557
EBIT
6,405
44,797
136,951
107,282
112,634
EBITDA
8,825
--
--
--
116,080
Reconciled Cost of Revenue
14,085
12,977
10,882
6,481
5,385
Reconciled Depreciation
2,420
1,890
1,336
2,362
3,446
Net Income from Continuing Operation Net Minority Interest
55,182
99,652
141,209
106,140
101,418
Total Unusual Items Excluding Goodwill
0
--
0
0
0
Total Unusual Items
0
--
0
0
0
Normalized EBITDA
8,825
46,687
138,287
109,644
116,080
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 4/14/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: